Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Brentuximab Vedotin and Nivolumab for Relapsed or Refractory Classic Hodgkin Lymphoma: Long-Term Follow-up Results from the Single-Arm Phase 1/2 Study

Alison J. Moskowitz, MD, Ranjana H Advani, MD, Nancy L. Bartlett, MD, Julie M Vose, MDMBA, Radhakrishnan Ramchandren, MD, Tatyana A. Feldman, MD, Ann S. LaCasce, MD MMSc, Beth A. Christian, MD, Stephen M Ansell, MD PhD, Craig H. Moskowitz, Lisa Brown, David Taft, Sahar Ansari, Daniel E. Zak, PhD, Mariana Sacchi, MD, Thomas Manley, MD, Alex F. Herrera, MD

Blood (2019) 134 (Supplement_1): 238.

https://doi.org/10.1182/blood-2019-122576

Published: 2019

Journal Articles

Phase 1 Study of Adct-301 (Camidanlumab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody Drug Conjugate, in Relapsed/Refractory Classical Hodgkin Lymphoma

Mehdi Hamadani, MD, Graham P. Collins, MB BS DPhil, Felipe Samaniego, MD, Alexander I Spira, MD, Andrew Davies, John Radford, MD FRCP, Paolo Caimi, MD, Tobias Menne, MD PhD, Joseph Boni, PhD, Hans Cruz, Jay Feingold, MD PhD, Shui He, PhD, Jens Wuerthner, Steven M. Horwitz, MD

Blood (2018) 132 (Supplement 1): 928.

https://doi.org/10.1182/blood-2018-99-118198

Published: 2018

Journal Articles

Neurological Adverse Events Determine Morbidity and Mortality Post Allogeneic Hematopoietic Cell Transplantation

Ioanna Sakellari, Eleni Gavriilaki, MD, Sotirios Papagiannopoulos, Maria Gavriilaki, MD, Ioannis Batsis, Despina Mallouri, Anna Vardi, MD PhD, Varnavas Constantinou, Michalis Iskas, Marianna Masmanidou, Evangelia Yannaki, MD, Triantafyllos Geroukis, MD, Dimitrios Kazis, Vasilis Kimiskidis, Achilles Anagnostopoulos

Blood (2018) 132 (Supplement 1): 5732.

https://doi.org/10.1182/blood-2018-99-112032

Published: 2018

Journal Articles

Anti α4β7 Integrin Monoclonal Antibody (Vedolizumab) for the Treatment of Steroid-Resistant Severe Intestinal Acute Graft Versus Host Disease

Ivetta Danylesko, Roni Shouval, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Arie Apel, MD, Avichai Shimoni, MD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 3263.

https://doi.org/10.1182/blood.V130.Suppl_1.3263.3263

Published: 2017

Journal Articles

Zika and Chikungunya Virus and Risk for Venous Thromboembolism

Eduardo Ramacciotti, Leandro Agati, Valeria Aguiar, Thomas Wakefield, Anthony Comerota, MD, Jeanine Walenga, Walter Jeske, Jawed Fareed, PhD

Blood (2017) 130 (Supplement 1): 4883.

https://doi.org/10.1182/blood.V130.Suppl_1.4883.4883

Published: 2017

Journal Articles

Anti-CD20 Monoclonal Antibody Therapy for Immune Modulation Across a Range of Autoimmune Diseases

John Macisaac, BSc, Reda Sidiqqi, B.Sc, Erin Jamula, MSc, Na Li, PhD, Steven Baker, MD, Kathryn Elizabeth Webert, MDFRCPC,MSc, Nancy Heddle, MSc, Donald M Arnold, MD

Blood (2017) 130 (Supplement 1): 4936.

https://doi.org/10.1182/blood.V130.Suppl_1.4936.4936

Published: 2017

Journal Articles

Inflammatory and Autoimmune Manifestations Associated with Lymphoid Neoplasms: A French Multicenter Retrospective Study

Vincent Jachiet, Eric Grignano, Arsène Mekinian, Paul Coppo, MD PhD, Olivier Fain

Blood (2016) 128 (22): 5335.

https://doi.org/10.1182/blood.V128.22.5335.5335

Published: 2016

Journal Articles

Effective Treatment of Severe Chronic Graft Versus Host Disease with a Combination of B-Cell Depletion and Tyrosine Kinase Inhibition

Lotte E. van der Wagen, MD, Liane te Boome, MD, Inger Nijhof, MD, Marieke Schoordijk, Ellen Meijer, MD PhD, Jurgen Kuball, MD PhD

Blood (2016) 128 (22): 4565.

https://doi.org/10.1182/blood.V128.22.4565.4565

Published: 2016

Journal Articles

Venetoclax Combined with Bortezomib and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma

Philippe Moreau, Asher A. Chanan-Khan, MD, Andrew W. Roberts, Amit B. Agarwal, Thierry Facon, MD, Shaji Kumar, MD, Cyrille Touzeau, Jaclyn Cordero, Jeremy Ross, Wijith Munasinghe, Jia Jia, Ahmed H. Salem, Joel Leverson, Paulo Maciag, Maria Verdugo, Simon J. Harrison

Blood (2016) 128 (22): 975.

https://doi.org/10.1182/blood.V128.22.975.975

Published: 2016

Journal Articles

Updated Results on the Clinical Activity of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Patients with CLL Previously Treated with an Inhibitor of the B-Cell Receptor Signaling Pathway

Jeffrey P. Sharman, Andrei R. Shustov, Mitchell R. Smith, Christopher T. Hagenstad, Kathryn S. Kolibaba, Esteban Abella-Dominicis, Danjie Zhang, Siddhartha Mitra, Christopher A. Yasenchak, Farrukh T. Awan

Blood (2016) 128 (22): 3225.

https://doi.org/10.1182/blood.V128.22.3225.3225

Published: 2016

Journal Articles

Guilain-Barre’ Syndrome (GBS) Post Adult Cord Blood Transplantation In a Patient With Chronic Lymphocytic Leukemia (CLL)

Melhem M. Solh, MD, Tori Smith, Jason Balls, Megan Smith, Yasser Khaled, MD

Blood (2013) 122 (21): 5497.

https://doi.org/10.1182/blood.V122.21.5497.5497

Published: 2013

Journal Articles

Soluble Epoxide Hydrolase As An Anti-Inflammatory Target Of The Thrombolytic Stroke Drug Candidate Smtp-7

Eriko Suzuki, PhD, Naoki Matsumoto, Keita Shibata, PhD, Terumasa Hashimoto, MD, PhD, Kazuo Honda, PhD, Keiji Hasumi, PhD

Blood (2013) 122 (21): 2336.

https://doi.org/10.1182/blood.V122.21.2336.2336

Published: 2013

Journal Articles

A Phase II Clinical Trial of Fludarabine and Cyclophosphamide Followed by Thalidomide for Angioimmunoblastic Lymphoma (AITL), an NCRI Clinical Trial. CRUK C17050/A5671

William M Townsend, MRCP, Roderick J. Johnson, MD, Nicholas Counsell, Humra Shah, Bryson Pottinger, Katy Evans, Caroline Wickham, Paul Smith, Rudin Claudius, MD FRCP FRCPath

Blood (2012) 120 (21): 3642.

https://doi.org/10.1182/blood.V120.21.3642.3642

Published: 2012

Journal Articles

Guillain-Barre Syndrome Following Azacitidine for Treatment of Myelodysplastic Syndrome.

Phoebe E. Harvey, MD, Mary Lynn R. Nierodzik, MD, Jennifer Wu, MD

Blood (2009) 114 (22): 4861.

https://doi.org/10.1182/blood.V114.22.4861.4861

Published: 2009

Journal Articles

Plitidepsin Is Active in Peripheral T-Cell Lymphoma (PTCL): A Subset Analysis from An Ongoing Multicenter Phase II Trial.

Christophe Ferme, MD, Maria Victoria Mateos, MD, PhD, Sergio Szyldergemajn, MD, Emanuele Zucca, MD, Jose Espinoza, MD, Javier Briones, MD, Franck Morschhauser, MD, Christian Gisselbrecht, MD, Vincent Ribrag, MD

Blood (2008) 112 (11): 1566.

https://doi.org/10.1182/blood.V112.11.1566.1566

Published: 2008

Journal Articles

Guillain-Barre Syndrome Complicating Multiple Myeloma

Afsheen N Iqbal, Quan Le, Rajeev Motiwala, Leila J Clay, Tej Motiwala, Nikoletta Lendvai, David S. Siegel, Stuart L Goldberg

Blood (2008) 112 (11): 5135.

https://doi.org/10.1182/blood.V112.11.5135.5135

Published: 2008

Journal Articles

Post Allogeneic Stem Cell Transplant Complications - Single Centre Experience from Pakistan.

Shahid Raza, MD, FCPS Pak, Khalil Ullah, MD, FCPS Pak, Parvez Ahmed, MD, FCPS Pak, Tariq Satti, MD, FCPS Pak, Badshah Khan, MD, FCPS Pak

Blood (2007) 110 (11): 4955.

https://doi.org/10.1182/blood.V110.11.4955.4955

Published: 2007

Journal Articles

A Case of Peripheral Neuropathy Combined with Leukoencephalopathy after Injection with Intrathecal Methotrexate and Vincristine.

Hae-sang Lee, M.D., Hyun Joo Jung, M.D., Jun Eun Park, MD, PhD

Blood (2007) 110 (11): 4348.

https://doi.org/10.1182/blood.V110.11.4348.4348

Published: 2007

Journal Articles

Nelarabine Can Be Safely Incorporated into an Intensive, Multiagent Chemotherapy Regimen for the Treatment of T-Cell Acute Lymphocytic Leukemia (ALL) in Children: A Report of the Children’s Oncology Group (COG) AALL00P2 Protocol for T-Cell Leukemia.

Kimberly Dunsmore, MD, Meenakshi Devidas, Phd, Michael J. Borowitz, MD, Naomi Winick, MD, Stephen Hunger, MD, William L. Carroll, MD, Bruce Camitta, MD

Blood (2006) 108 (11): 1864.

https://doi.org/10.1182/blood.V108.11.1864.1864

Published: 2006

Journal Articles

Guillain Barre Syndrome: A Late Complication of Autologous Stem Cell Transplant?.

Sandeep Kodityal, MD, Amith Kodityal, BS, George S. Carrum, MD

Blood (2005) 106 (11): 5391.

https://doi.org/10.1182/blood.V106.11.5391.5391

Published: 2005

NARROW

Brentuximab Vedotin and Nivolumab for Relapsed or Refractory Classic Hodgkin Lymphoma: Long-Term Follow-up Results from the Single-Arm Phase 1/2 Study

Phase 1 Study of Adct-301 (Camidanlumab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody Drug Conjugate, in Relapsed/Refractory Classical Hodgkin Lymphoma

Neurological Adverse Events Determine Morbidity and Mortality Post Allogeneic Hematopoietic Cell Transplantation

Anti α4β7 Integrin Monoclonal Antibody (Vedolizumab) for the Treatment of Steroid-Resistant Severe Intestinal Acute Graft Versus Host Disease

Zika and Chikungunya Virus and Risk for Venous Thromboembolism

Anti-CD20 Monoclonal Antibody Therapy for Immune Modulation Across a Range of Autoimmune Diseases

Inflammatory and Autoimmune Manifestations Associated with Lymphoid Neoplasms: A French Multicenter Retrospective Study

Effective Treatment of Severe Chronic Graft Versus Host Disease with a Combination of B-Cell Depletion and Tyrosine Kinase Inhibition

Venetoclax Combined with Bortezomib and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma

Updated Results on the Clinical Activity of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Patients with CLL Previously Treated with an Inhibitor of the B-Cell Receptor Signaling Pathway

Guilain-Barre’ Syndrome (GBS) Post Adult Cord Blood Transplantation In a Patient With Chronic Lymphocytic Leukemia (CLL)

Soluble Epoxide Hydrolase As An Anti-Inflammatory Target Of The Thrombolytic Stroke Drug Candidate Smtp-7

A Phase II Clinical Trial of Fludarabine and Cyclophosphamide Followed by Thalidomide for Angioimmunoblastic Lymphoma (AITL), an NCRI Clinical Trial. CRUK C17050/A5671

Guillain-Barre Syndrome Following Azacitidine for Treatment of Myelodysplastic Syndrome.

Plitidepsin Is Active in Peripheral T-Cell Lymphoma (PTCL): A Subset Analysis from An Ongoing Multicenter Phase II Trial.

Guillain-Barre Syndrome Complicating Multiple Myeloma

Post Allogeneic Stem Cell Transplant Complications - Single Centre Experience from Pakistan.

A Case of Peripheral Neuropathy Combined with Leukoencephalopathy after Injection with Intrathecal Methotrexate and Vincristine.

Nelarabine Can Be Safely Incorporated into an Intensive, Multiagent Chemotherapy Regimen for the Treatment of T-Cell Acute Lymphocytic Leukemia (ALL) in Children: A Report of the Children’s Oncology Group (COG) AALL00P2 Protocol for T-Cell Leukemia.

Guillain Barre Syndrome: A Late Complication of Autologous Stem Cell Transplant?.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only